The inhibition of the antidotal activity of vitamin K1 against coumarin anticoagulant drugs by its chloro analogue

1960 ◽  
Vol 16 (9) ◽  
pp. 428-429 ◽  
Author(s):  
J. Lowenthal ◽  
J. A. MacFarlane ◽  
K. M. McDonald
Keyword(s):  
Vitamin K1 ◽  
Coumarin Anticoagulant ◽  
Anticoagulant Drugs ◽  
Antidotal Activity

CHEMISTRY OF COUMARIN ANTICOAGULANT DRUGS

1955 ◽  
Vol 11 (1) ◽  
pp. 56-61 ◽  
Author(s):  
R. B. HUNTER ◽  
D. M. SHEPHERD
Keyword(s):  
Coumarin Anticoagulant ◽  
Anticoagulant Drugs

PLASMA VITAMIN K1-2,3-EPOXIDE AS DIAGNOSTIC AID TO DETECT SURREPTITIOUS INGESTION OF ORAL ANTICOAGULANT DRUGS

The Lancet ◽  
1983 ◽  
Vol 321 (8324) ◽  
pp. 596-597 ◽  
Author(s):  
H. Bechtold ◽  
D. Trenk ◽  
E. Jähnchen ◽  
T. Meinertz
Keyword(s):  
Oral Anticoagulant ◽  
Plasma Vitamin ◽  
Vitamin K1 ◽  
Diagnostic Aid ◽  
Anticoagulant Drugs

HEREDITARY RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS IN MAN AND RAT

1968 ◽  
Vol 151 (1) ◽  
pp. 913-931 ◽  
Author(s):  
Robert A. O'Reilly ◽  
Judith G. Pool ◽  
Paul M. Aggeler
Keyword(s):  
Coumarin Anticoagulant ◽  
Anticoagulant Drugs

scholarly journals Studies on Coumarin Anticoagulant Drugs

1969 ◽  
Vol 244 (5) ◽  
pp. 1303-1305
Author(s):  
R A O'Reilly ◽  
J I Ohms ◽  
C H Motley
Keyword(s):  
Coumarin Anticoagulant ◽  
Anticoagulant Drugs

Studies on the Coumarin Anticoagulant Drugs : A Comparison of the Pharmacodynamics of Dicumarol and Warfarin in Man

1964 ◽  
Vol 11 (01) ◽  
pp. 001-022 ◽  
Author(s):  
Robert A. O’Reilly ◽  
Paul M. Aggeler ◽  
Lois S. Leong
Keyword(s):  
Reticuloendothelial System ◽  
Apparent Volume ◽  
Volume Of Distribution ◽  
Unchanged Drug ◽  
Duration Of Action ◽  
Specific Chemical ◽  
Coumarin Anticoagulant ◽  
Anticoagulant Drugs ◽  
Duration Of Response ◽  
Size Characteristic

SummaryThe pharmacodynamic and prothrombinopénie effects of the coumarin anticoagulant drugs warfarin and dicumarol were compared in man by means of specific chemical assays for the drugs and the Quick prothrombin time for the response. The absorption of warfarin was rapid and complete, and the prothrombinopénie response was similar after administration by any route. Absorption of dicumarol as a solution or powder was rapid while as whole tablets it was often slow. Dicumarol in solution taken orally produced higher maximum concentrations of drug in plasma, more rapid absorption rates, less unchanged drug in stool and an earlier and greater prothrombin complex response than the tablets. Only a slight effect was produced by varying the formulation of warfarin. In all subjects 15 to 30% of the oral dose of dicumarol was recovered as unchanged drug in the stool. Unchanged warfarin was not recovered from the stool in any experiment.The apparent volume of distribution (Vd) for warfarin and high doses of dicumarol was about 12.5% of body weight, approximately the size of the albumin space. The long half-time of disappearance (t½) of both drugs, their prolonged duration of action, small volume of distribution, and lack of excretion of unchanged drug in the urine are probably related to their high degree of binding to plasma proteins. The t½ and Vd for warfarin are independent of dose size; the unusual dependency of these parameters on dose size with dicumarol suggests tissue uptake, perhaps by the reticuloendothelial system.A good correlation was found between the t½ of warfarin and dicumarol and the magnitude and duration of response. Up to a certain point increasing the dose of these drugs hastened the occurrence of hypoprothrombinemia ; beyond a dose size characteristic for each individual no further hastening could be obtained.A substance extracted from the stool of subjects receiving dicumarol intravenously and orally is probably a metabolite of the drug.

scholarly journals STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN*

1963 ◽  
Vol 42 (10) ◽  
pp. 1542-1551 ◽  
Author(s):  
Robert A. O'Reilly ◽  
Paul M. Aggeler ◽  
Lois S. Leong
Keyword(s):  
Coumarin Anticoagulant ◽  
Anticoagulant Drugs

HEREDITARY RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS IN MAN AND RAT

1968 ◽  
Vol 151 (2 Pharmacogenet) ◽  
pp. 913-931 ◽  
Author(s):  
Robert A. O'Reilly ◽  
Judith G. Pool ◽  
Paul M. Aggeler†
Keyword(s):  
Coumarin Anticoagulant ◽  
Anticoagulant Drugs

Hereditary Transmission of Exceptional Resistance to Coumarin Anticoagulant Drugs

1964 ◽  
Vol 271 (16) ◽  
pp. 809-815 ◽  
Author(s):  
Robert A. O'Reilly ◽  
Paul M. Aggeler ◽  
M. Silvija Hoag ◽  
Lois S. Leong ◽  
Mona L. Kropatkin
Keyword(s):  
Coumarin Anticoagulant ◽  
Anticoagulant Drugs
Sign in / Sign up

Export Citation Format

Share Document